6505--Epoetin RFI
Closed Pre-Solicitation Posted
- Solicitation number
- 36E79725Q0004
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is conducting market research to procure Epoetin Vials for multiple federal agencies, including VA, DoD, Indian Health Service, Bureau of Prisons, and Federal Health Care Center. The procurement aims to establish a national mandatory requirements contract with the primary objective of securing pricing lower than current Federal Supply Schedule or open market rates. Key contract requirements include providing a unique National Drug Code (NDC), submitting a manufacturer commitment letter if not the direct manufacturer, and having established business-to-business agreements with Pharmaceutical Prime Vendors. Potential offerors must specify their company size under NAICS code 325412 and indicate whether they can manufacture at least 50% of the product if identified as a small business. The market research questionnaire requires responses by April 16, 2025, with companies expected to demonstrate their ability to supply products within 60 days of contract award.
The solicitation is not designated for any specific set-aside, allowing both small and large businesses to compete. The contract will cover seven different Epoetin vial strengths ranging from 2000 to 40000 units/ml, with estimated annual usage volumes between 3,181 and 63,901 vials per strength. The proposed contract structure includes a base year with the potential for four additional option years, designed to provide procurement continuity and consistent product availability. While specific award values are not explicitly stated, the large volume of vials and multi-agency participation suggest a significant potential contract value. The procurement focuses on a comprehensive, standardized national contract that will consolidate pharmaceutical purchasing across multiple federal healthcare organizations, potentially streamlining procurement processes and reducing overall government pharmaceutical acquisition costs.
Notice text
MARKET RESEARCH QUESTIONNAIRE
Company Name: _________________________
I am conducting market research for the procurement of Epoetin Vials for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in a national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:
1. Is your Company able to meet the following minimum requirements:
National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Does your company have a unique NDC (Labeler Code)?_____________
If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer:_________________
Would you be able to provide a letter of commitment from the manufacturer of the offered drug?_____________
Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs?_________
d. Under NAICS code 325412, is your company size (check one):
Large Business ______
Small Business ______
e. If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________
f. Is the offered end product U.S end-made or designated end made product?_________
g. Can your company meet the following product, bottle size and usage:
ITEM
DESCRIPTION
PKG SIZE(Vials)
TOTAL EST ANNUAL USAGE (Vials)
1
EPOETIN 2000UNIT/ML INJ,SOLN
1
43,026
2
EPOETIN 3000UNIT/ML INJ,SOLN
1
44,306
3
EPOETIN 4000UNIT/ML INJ,SOLN
1
33,018
4
EPOETIN 10000UNIT/ML INJ,SOLN
1
63,901
5
EPOETIN 20000UNIT/2ML INJ,MDV
1
3,181
6
EPOETIN 20000UNIT/ML INJ,SOLN
1
14,418
7
EPOETIN 40000UNIT/ML INJ,SOLN
1
14,540
2 . Is your Company interested in submitting a response to a solicitation?________
3. As this is a national standardized contract, our preference is for a base plus four option years to provide our customers continuity and consistency of product by allowing long term committed purchases of your product. If interested, please indicate Base year and how many Option periods, not to exceed 4._________________
4. If an award were to be made based on the above requirements, would your company be able to begin supplying the product in the estimated quantities within 60 days of the contract award date?
______________________________________________________________________
5. If your company is not interested in participating, please respond with the reason why. This aids our market research for future procurements.
______________________________________________________________________
If you could provide your response as soon as possible, it would be greatly appreciated. Please contact me at Amber.Zavala@va.gov if you have any questions.
Files
| File | Type | Posted |
|---|---|---|
| 36E79725Q0004_1.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| DA10 -- RFI - Lab EP Evaluator Subscriptions | Veterans Integrated Service Network 16 | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6550--Abbott Architect i1000 Reagents | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity